Total parenteral nutrition (TPN) is a supportive therapy commonly used
in clinical oncology, in spite of its possible interference on tumor
growth. In fact, studies performed on animals have demonstrated that T
PN increases tumor growth and that load and quality of amino acids are
probably the main factors involved. In contrast, some authors obtaine
d a decrease in tumor growth using a special amino acids mixture or a
TPN formula rich in lipids. However, data collected on animals are not
transferable to humans owing to the large difference between tumor-ho
st weight ratio and tumor doubling time. Analysis of the studies on ef
fect of TPN on tumor growth in humans has not demonstrated a bad effec
t, but the results reported in the literature are limited by the small
number of patients, the lack of a sure and reproducible method to ana
lyze tumor growth, and some methodologic defects. In conclusion, it is
not evident that TPN is dangerous for cancer patients. However, it ma
y be possible in the future to employ different formulas to improve th
e host nutritional status and inhibit tumor growth.